Skip to content
CED Clinic
Contact Us Book Consultation GLP-1 Care
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
  • Facebook
  • X
  • Email
  • Instagram
  • YouTube
  • Substack
  • Dr Caplan’s Book
CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
Subscribe
Close

Search

Exclusive
Adolescent-Centered Cannabis Messaging in Clinical Settings
August 15, 2026
Adolescent-Centered Cannabis Messaging in Clinical Settings
High-THC Cannabis Increased Inflammation Without Improving Insulin Sensitivity
August 15, 2026
High-THC Cannabis Increased Inflammation Without Improving Insulin Sensitivity
MA Cannabis Control Commission finds 13 cannabis products with inaccurate labeled THC potency
August 15, 2026
MA Cannabis Control Commission finds 13 cannabis products with inaccurate labeled THC potency
Cannabis Is Not Vascularly Inert: Proatherogenic Inflammation in Youth
August 15, 2026
Cannabis Is Not Vascularly Inert: Proatherogenic Inflammation in Youth
Protective psychological mechanisms against adolescent cannabis and kratom use
August 15, 2026
Protective psychological mechanisms against adolescent cannabis and kratom use
IcoSema COMBINE 4 Type 2 Diabetes Trial | IcoSema COMBINE 4 trial
August 15, 2026
Once-Weekly IcoSema for Type 2 Diabetes: What COMBINE 4 Found
Cannabis Craving & Cross-Substance Use | cannabis use disorder trial data | cannabis craving cross-substance substitution
August 15, 2026
Cannabis Craving and Cross-Substance Use: What Pooled Trial Data From 829 Patients Show
cannabis butternut squash sage spread finished recipe styled as the emotional anchor with warm editorial food photography
August 15, 2026
Cannabis Butternut Squash Sage Spread Recipe
Study Finds CBD Inhibits Dental Plaque Bacteria and Biofilm Formation
August 15, 2026
Study Finds CBD Inhibits Dental Plaque Bacteria and Biofilm Formation
Georgia Regulators Propose Allowing Home Delivery of Medical Cannabis
August 15, 2026
Georgia Regulators Propose Allowing Home Delivery of Medical Cannabis
Medical Marijuana Improves Pain, Sleep And Anxiety In Women With Endometriosis While ...
August 15, 2026
Medical Marijuana Improves Pain, Sleep And Anxiety In Women With Endometriosis While …
CDC Report: Emergency Room Diagnoses for Severe Marijuana-Related Vomiting Illness Spike
August 15, 2026
CDC Report: Emergency Room Diagnoses for Severe Marijuana-Related Vomiting Illness Spike
The Enzyme Behind Cannabis and Endocannabinoid Regulation
August 15, 2026
The Enzyme Behind Cannabis and Endocannabinoid Regulation
water-dispersible cannabis drops finished recipe styled as the emotional anchor with warm editorial food photography
August 14, 2026
How to Make Water-Dispersible Cannabis Drops
cannabis spiced pear shrub spritzer finished recipe styled as the emotional anchor with warm editorial food photography
August 14, 2026
Cannabis Spiced Pear Shrub Spritzer Recipe
Government building in Georgia representing the state medical cannabis delivery rulemaking process
August 14, 2026
Georgia Proposes Home Delivery for Medical Cannabis Patients
Nabiximols vs Cannabis Decoction MS Spasticity | nabiximols cannabis decoction MS spasticity study
August 14, 2026
Nabiximols vs. Cannabis Decoction for MS Spasticity: What a New Formulation Comparison Study Found
Massachusetts Cannabis Regulators Reveal THC Potency Audit Results
August 14, 2026
Massachusetts Cannabis Regulators Reveal THC Potency Audit Results
Massachusetts cannabis regulators catch mislabeled flower in THC audit
August 14, 2026
Massachusetts cannabis regulators catch mislabeled flower in THC audit
Cbd Gummies Good For Inflammation: A Data Driven Look At Efficacy, Quality, And Reality ...
August 14, 2026
Cbd Gummies Good For Inflammation: A Data Driven Look At Efficacy, Quality, And Reality …
How to Choose the Right Edible Dosage
August 14, 2026
How to Choose the Right Edible Dosage
'Scromiting' Can Happen With Frequent Cannabis Use. What Are the Symptoms?
August 14, 2026
‘Scromiting’ Can Happen With Frequent Cannabis Use. What Are the Symptoms?
ced unsplash KJbK6WqpGd4
August 14, 2026
Massachusetts THC Potency Audit Flags 13 Cannabis Flower Products
US: Georgia medical cannabis registry surges 22% after law eases access
August 14, 2026
US: Georgia medical cannabis registry surges 22% after law eases access
Canada Invests $24 Million To Study Impact Of Cannabis On Brain Health
August 14, 2026
Canada Invests $24 Million To Study Impact Of Cannabis On Brain Health
Contrary To Expectations, Study Shows Cannabis Linked To Fewer Ectopic Heartbeats
August 14, 2026
Contrary To Expectations, Study Shows Cannabis Linked To Fewer Ectopic Heartbeats
Dr. Mitch: Federal government invests $24 million for cannabis and brain health research
August 14, 2026
Dr. Mitch: Federal government invests $24 million for cannabis and brain health research
Could Truly Water-Soluble Cannabidiol Improve Oral Dosing?
August 14, 2026
Could Truly Water-Soluble Cannabidiol Improve Oral Dosing?
Oral Semaglutide for Alcohol Use Disorder Trial | oral semaglutide alcohol use disorder trial
August 14, 2026
Oral Semaglutide for Alcohol Use Disorder: What a New Randomized Trial Found
cannabis eggplant caponata spread finished recipe styled as the emotional anchor with warm editorial food photography
August 14, 2026
Cannabis Eggplant Caponata Spread Recipe
Medical Cannabis Provides Relief for Endometriosis Symptoms
August 14, 2026
Medical Cannabis Provides Relief for Endometriosis Symptoms
Home/Cannabis Science/COVID-19 Alcohol and Cannabis Use: Income, Race, Gender Intersections
COVID-19 Alcohol and Cannabis Use: Income, Race, Gender Intersections
Cannabis Science

COVID-19 Alcohol and Cannabis Use: Income, Race, Gender Intersections

By Benjamin Caplan, MD
11 Min Read
Comments Off on COVID-19 Alcohol and Cannabis Use: Income, Race, Gender Intersections



By Dr. Benjamin Caplan, MD  |  Board-Certified Family Physician, CMO at CED Clinic  |  Evidence Watch

Clinical Insight | CED Clinic

A large Canadian survey spanning nearly two years of the COVID-19 pandemic found that higher household income, not lower, was linked to heavier drinking, and that racial and ethnic minority individuals at middle income levels had elevated odds of heavy episodic drinking compared to White individuals at the lowest income bracket. These findings underscore how income, race, gender, and age interact in complex ways to shape substance use risk during a public health crisis.

Table of Contents

  • Beyond Income Alone: How Race, Gender, and Age Reshaped Alcohol and Cannabis Risk During COVID-19
      • Beyond Income Alone: How Race, Gender, and Age Reshaped Alcohol and Cannabis Risk During COVID-19
  • Newsletter Signup Form
      • Read next
      • Related

Beyond Income Alone: How Race, Gender, and Age Reshaped Alcohol and Cannabis Risk During COVID-19

Talk to Dr. Caplan

Want to apply this research to your own care?

30,000+ patients treated. Appointments in Massachusetts and via telemedicine.

Book a consultation →GLP-1 + cannabis program
BC

Dr. Benjamin Caplan, MD

Board-certified Family Medicine

20+ years in cannabis medicine. CMO, CED Clinic. Author, Penguin Random House. Principal Investigator in multiple studies.

Full bio →

Related reading

  • Conditions A–Z →
  • Cannabis & anxiety →
  • Cannabis & sleep →
  • Cannabinoid profiles →

Wherever you are

Dr. Caplan offers consultations for complex conditions and wellness needs. Patients from across the US and internationally are welcome.

Book a consultation →

A Canadian repeated cross-sectional survey of nearly 9,000 adults finds that socio-economic status interacts with gender, ethnicity, and age to shape pandemic-era substance use in ways that defy simple assumptions, though the study’s design cannot prove cause and effect.

CED Clinical Relevance
#72
High Relevance
Intersectional findings on substance use risk during a public health crisis carry direct implications for clinical screening and culturally targeted harm-reduction strategies.
Alcohol Use
Cannabis Use
Health Disparities
COVID-19 Pandemic
Intersectional Epidemiology
Why This Matters

The COVID-19 pandemic altered substance use patterns in ways that public health systems are still grappling with. Most prior studies examined income or race as independent risk factors, but real-world vulnerability rarely operates along a single axis. If income, race, gender, and age interact to create pockets of elevated risk that standard screening tools miss, then clinical and public health responses built on simple socio-economic targeting may be directing resources to the wrong places. Understanding these intersections is essential for any clinician who screens for alcohol or cannabis misuse in a post-pandemic population.

Study at a Glance
Study Type Repeated cross-sectional observational survey (9 waves)
Population Canadian adults aged 18 and older, English-speaking, recruited via web panel (Asking Canadians/Delvinia)
Intervention / Focus Socio-economic status indicators (household income, education, employment) and their intersections with gender, ethnoracial background, and age
Comparator Reference groups: income less than $40,000; high school diploma or less; employed; men; White ethnoracial background; age 18 to 39
Primary Outcomes Heavy episodic drinking, perceived increase in alcohol use, past-week cannabis use, perceived increase in cannabis use
Sample Size 8,943 participants across nine survey waves (approximately 1,000 per wave)
Journal BMC Public Health
Year 2025
DOI / PMID 10.1186/s12889-025-25423-z
Funding Source Not explicitly stated in the available text
Clinical Summary

The COVID-19 pandemic created a natural experiment in which economic disruption, social isolation, and psychological distress converged across socio-economic lines. This study, led by Somé and colleagues at the Centre for Addiction and Mental Health in Toronto, recruited approximately 1,000 English-speaking Canadian adults per wave across nine consecutive web-based surveys from May 2020 to January 2022. The research team applied an intersectional analytical framework, testing not just whether income, education, and employment predicted alcohol and cannabis outcomes, but whether those associations differed by gender, ethnoracial background, and age. Backward stepwise logistic regression with Bonferroni correction was used to model four outcomes: heavy episodic drinking, perceived increase in alcohol use, past-week cannabis use, and perceived increase in cannabis use.

The core findings challenge simple narratives. Moderate and high household income were associated with greater odds of heavy episodic drinking and self-reported increases in alcohol use, as was unemployment. Racial and ethnic minority individuals with household incomes of $40,000 to $79,999 had greater odds of heavy episodic drinking than White individuals at the lowest income tier. University education appeared protective, particularly for women and older adults, for both alcohol and cannabis outcomes. The authors note critical limitations: response rates ranged from only 10 to 18 percent, all measures were self-reported and retrospective, and the binary White versus racial minority grouping conceals important heterogeneity. The authors call for longitudinal, representative studies to determine whether these intersectional patterns reflect causal processes.

Dr. Caplan’s Analysis
A physician’s reading of the evidence

Beyond Income Alone: How Race, Gender, and Age Reshaped Alcohol and Cannabis Risk During COVID-19

We tend to assume that financial hardship drives drinking, that the lower you are on the economic ladder, the more you reach for a drink to cope. But a Canadian study spanning nearly two years of the pandemic found a more complicated picture: higher income was associated with heavier drinking, mid-income racial minority individuals drank heavily at rates exceeding low-income White individuals, and a university education appeared to protect women in ways it did not protect men. The rules of pandemic drinking turned out to depend heavily on who you were, not just how much money you had. What this study genuinely contributes is its intersectional architecture. By testing interaction terms rather than simply stacking variables, the authors reveal that income does not operate uniformly across demographic groups. A mid-income Black or Indigenous Canadian faced different odds of heavy episodic drinking than a mid-income White Canadian at the same household income level. That is a finding that standard models, which treat each predictor as independent, would never surface. Before any criticism, this matters. It validates what many of us in clinical practice have long observed: patients do not arrive with a single socio-economic label, and the confluence of identity markers shapes their risk in ways that simple screening questions about income or employment status cannot capture.

The central methodological problem, however, is that all of these findings rest on self-reported, retrospective assessments of substance use collected from a commercial web panel with response rates of 10 to 18 percent. In epidemiological terms, asking people whether they drank more during the pandemic than before is a perceived-change measure, not a prospective behavioral observation. It is the difference between measuring someone’s sleep with a polysomnogram and asking them over breakfast whether they think they slept well. Memory, mood, framing effects, and social desirability all color the answer, and those distortions are not random across income and racial groups. Similarly, if you surveyed only the people who answered the phone during dinner, you might conclude that most people are home at six in the evening, but you would be missing everyone who was not. The 10 to 18 percent who completed these surveys may systematically differ in their substance use habits, health concerns, and free time from the 82 to 90 percent who did not. This means the intersectional patterns the authors describe could be real population phenomena or artifacts of differential non-response, and we cannot currently distinguish between the two.

The aggregation of diverse racial and ethnic groups into a single binary variable further limits the precision of the race-income interaction finding. Grouping Indigenous, Black, Asian, Arab, and Latinx communities under “racial minority” for a health analysis is a bit like diagnosing all respiratory symptoms as “lung problems”: technically defensible when you have too few cases to do better, but obscuring clinically meaningful differences between populations with very different histories, stressors, and relationships to alcohol and cannabis. To a patient concerned about their pandemic drinking, I would say that this study reminds us stress and substance use do not follow a simple rulebook, and their patterns are worth discussing regardless of economic situation. To a colleague, I would emphasize the screening signal: mid-income racial minority patients may not self-identify as high-risk and may not be flagged by standard tools, so a more thorough substance use history is warranted. To a policymaker, I would urge caution: the direction of these findings is plausible and clinically resonant, but the data quality does not yet support major resource allocation decisions. Intersectional analysis is not methodological decoration. It can reveal risk concentrations at specific combinations of socio-economic and demographic characteristics that are invisible to main-effects models, and those concentrations may matter more for health equity than average group differences.

Clinical Perspective

This study sits at the hypothesis-generating stage of the research arc. It does not replace prior single-wave pandemic substance use surveys but extends them by adding temporal breadth across four pandemic phases and, more importantly, by demonstrating that main-effects models of socio-economic risk are insufficient. The intersectional income-by-race finding for heavy episodic drinking aligns with broader structural vulnerability frameworks in public health but has not yet been replicated in longitudinal or probability-sampled populations, meaning it should be treated as a directional signal rather than an established fact.

From a pharmacological and safety standpoint, the study’s cannabis findings are particularly relevant for clinicians managing patients on medications with CYP450 interactions or those using cannabis alongside alcohol. The protective association between higher education and reduced cannabis use among women and older adults may reflect differential access to information about drug interactions and health literacy rather than a direct causal effect of education itself. Clinicians should consider incorporating brief, non-judgmental substance use screening into routine encounters with all patients, not just those who fit traditional socio-economic risk profiles, particularly during and after periods of widespread social disruption.

What Kind of Evidence Is This?

This is a repeated cross-sectional observational study using nine consecutive web-based surveys with pooled multivariable logistic regression. In the evidence hierarchy, it sits below cohort studies and randomized trials, generating associations rather than causal estimates. The single most important inference constraint is that different individuals were sampled at each wave, so apparent trends across pandemic phases may reflect changes in who responded, not changes in population-level behavior.

How This Fits With the Broader Literature

Prior pandemic substance use studies, including early Canadian and international cross-sectional surveys, generally reported increased alcohol consumption associated with psychological distress and economic disruption but rarely tested intersectional interactions. This study’s finding that higher income predicted heavier drinking is consistent with pre-pandemic epidemiological literature showing a positive income-alcohol consumption gradient in high-income countries, though the interaction with race and ethnicity adds a novel dimension. The protective effect of university education for women partially aligns with findings from European pandemic surveys showing that higher-educated women moderated their drinking more successfully during lockdowns.

The study challenges simpler accounts from single-wave pandemic surveys that treated socio-economic status as a monolithic predictor and extends the literature by demonstrating that intersectional modelling can surface risk patterns invisible to additive frameworks.

Could Different Analyses Have Changed the Result?

The most consequential analytic choice was the use of backward stepwise variable selection for the logistic regression models. Stepwise methods are known to be sensitive to multicollinearity and sampling variability, meaning that retained interaction terms may not replicate in an independent dataset. A pre-specified model based on prior theory, or a penalized regression approach such as LASSO, could have produced different retained terms and potentially altered which intersectional associations emerged as statistically significant.

Additionally, disaggregating the binary racial and ethnic minority category into its component groups, even at the cost of wider confidence intervals, could have revealed whether the income-race interaction is driven by one specific community or is consistent across all aggregated groups. This distinction has direct implications for intervention targeting.

Common Misreadings

The most likely overinterpretation is concluding that higher income causes heavier drinking during a pandemic or that mid-income racial minority Canadians are definitively at elevated risk. The cross-sectional design with self-reported retrospective perceived-change measures cannot establish causation regardless of statistical adjustment. The income-drinking association may reflect pre-existing consumption patterns, social drinking norms in higher-income groups, or differential non-response rather than a causal effect of income on pandemic-era drinking behavior.

A related misreading involves treating the binary racial and ethnic minority grouping as a meaningful clinical category. The aggregated finding masks substantial heterogeneity across Indigenous, Black, Asian, Arab, and Latinx communities, and should not be applied to any single group without disaggregated data.

Bottom Line

This study contributes a multi-wave, intersectional analysis showing that income, race, gender, and age interact in non-additive ways to shape pandemic-era alcohol and cannabis use in Canada. It does not establish causation, cannot be generalized to all Canadians, and relies on self-reported data from a low-response web panel. For practice now, it is best understood as a directional signal: standard income-based risk stratification may miss clinically meaningful vulnerability concentrations, and broader, more nuanced screening approaches are warranted.

Frequently Asked Questions

Does this study prove that higher income leads to heavier drinking?

No. The study found an association between higher household income and heavy episodic drinking, but because it is a cross-sectional survey, it cannot determine the direction of causation. Higher-income individuals may have had greater access to alcohol, different social norms around drinking, or pre-existing consumption patterns that the study could not measure.

Should people in racial minority groups be more worried about alcohol use?

The study found that racial and ethnic minority individuals at middle income levels had statistically elevated odds of heavy episodic drinking compared to White individuals at the lowest income level, but this finding comes from a broadly aggregated category that groups very different communities together. It is best understood as a signal that warrants further investigation, not a definitive risk label for any individual or community.

Does education protect against heavy drinking or cannabis use?

The study found that university education was associated with lower odds of heavy drinking and cannabis use, but primarily for women and older adults. Education may serve as a proxy for health literacy, social networks, or coping resources rather than being directly protective. These findings are associations and should not be interpreted as guarantees.

Can I apply these findings to myself or my patients?

These results describe population-level patterns from a Canadian web panel and cannot be applied to any specific individual. However, they do suggest that clinicians should consider substance use screening broadly across socio-economic groups and not assume that only lower-income patients are at risk for pandemic-related increases in drinking or cannabis use.

References

1. Somé NH, Imtiaz S, Wells S, de Oliveira C, Hamilton HA, Ali S, Elton-Marshall T, Rehm J, Shield K. Socio-economic factors associated with alcohol and cannabis use across waves of the COVID-19 pandemic: an intersectional analysis of a repeated cross-sectional survey. BMC Public Health. 2025;25:4045. https://doi.org/10.1186/s12889-025-25423-z

2. Cuzick J. A Wilcoxon-type test for trend. Statistics in Medicine. 1985;4(1):87-90.

Further Reading
Evidence WatchCannabis and Alcohol: What Clinicians Need to Know About Co-Use
CED Clinic BlogHealth Equity and Cannabis Access: Disparities That Persist
Evidence WatchSubstance Use Screening in Primary Care: Beyond Simple Risk Categories

Have thoughts on this? Share it:

X Share on X
in Share on LinkedIn
🦅 Share on BlueSky
📷 Follow on Instagram
📝 Read more on Substack
🔔 Subscribe via RSS







CED Clinic logo
Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

Leave a Message
Metabolic Care
Medical Consulting
Cannabis Care


Dr. Benjamin Caplan

RELATED READING AT CED CLINIC
Continue exploring the evidence

Alcohol and Tobacco More Harmful Than Marijuana, Government Study Confirms (2026)

A government study highlights the relative harms of alcohol and tobacco compared to marijuana, providing context for substance use risks.


Read More


Daily Anxiety and Depressive Symptoms Linked to Cannabis-Alcohol Co-Use

Explore the connection between daily anxiety, depression, and combined cannabis-alcohol use in diverse populations.


Explore Study


Higher Risk Cannabis Use Indicators Among People Living in Canada: A Cross-Sectional Study

A cross-sectional study identifying risk indicators for cannabis use disorder among Canadians, relevant for clinical screening.


Learn More

  • Newsletter Signup Form

    Enter your email address to subscribe to our newsletter.
  • Should be Empty:

Read next

Once-Weekly IcoSema for Type 2 Diabetes: What COMBINE 4 Found

Related

Tags:

Healthcare ProfessionalsResearch AnalysisSocio-economic determinants and intersectional factors (gender, ethnoracial background, age) associated with alcohol and cannabis use during the COVID-19 pandemic
Author

Benjamin Caplan, MD

Follow Me
Other Articles
Cannabis Use and Depression: What 47,000 Adults Show
Previous

Cannabis Use and Depression: What 47,000 Adults Show

Cannabis Use Among Adults Over 50: Prevalence and Medical Use Data
Next

Cannabis Use Among Adults Over 50: Prevalence and Medical Use Data

Book Now Intake Form
Dr. Benjamin Caplan, MD Learn About Dr. Caplan
Copyright 2026 — CED Clinic. All rights reserved.

Questions about this research?

Talk to Dr. Caplan →
CED Clinic
CED Clinic Home
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU